{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:34:17Z","timestamp":1772580857493,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jchromb.2020.122094","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T19:59:50Z","timestamp":1586203190000},"page":"122094","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Direct chiral LC-MS\/MS analysis of fexofenadine enantiomers in plasma and urine with application in a maternal-fetal pharmacokinetic study"],"prefix":"10.1016","volume":"1145","author":[{"given":"Leonardo Santos Ribeiro","family":"Pinto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel Tavares do","family":"Vale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda de Lima","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Paula","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Barbosa","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo Carvalho","family":"Cavalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera Lucia","family":"Lanchote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2020.122094_b0005","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1124\/dmd.112.048330","article-title":"Effect of coadministration of single and multiple doses of rifampicin on the pharmacokinetics of fexofenadine enantiomers in healthy subjects","volume":"41","author":"Kusuhara","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2020.122094_b0010","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/17425255.2018.1459565","article-title":"An update on the clinical pharmacokinetics of fexofenadine enantiomers","volume":"14","author":"Akamine","year":"2018","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jchromb.2020.122094_b0015","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/jphp.12687","article-title":"Influence of P-glycoprotein on the disposition of fexofenadine and its enantiomers","volume":"69","author":"Li","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jchromb.2020.122094_b0020","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4217","article-title":"Enantioseparation of (RS)-fexofenadine and enhanced detection as the diastereomeric amide and anhydride derivatives using liquid chromatography-mass spectrometry","volume":"32","author":"Malik","year":"2018","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2020.122094_b0025","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jpba.2006.07.033","article-title":"Determination of fexofenadine enantiomers in human plasma with high-performance liquid chromatography","volume":"43","author":"Miura","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2020.122094_b0030","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/(SICI)1099-081X(199810)19:7<455::AID-BDD130>3.0.CO;2-W","article-title":"Dose proportionality and comparison of single and multiple dose pharmacokinetics of fexofenadine (MDL 16455) and its enantiomers in healthy male volunteers","volume":"19","author":"Robbins","year":"1998","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.jchromb.2020.122094_b0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1365\/s10337-004-0310-0","article-title":"Enantioselective analyses of antihistaminic drugs by high-performance liquid chromatography","volume":"60","author":"Rustichelli","year":"2004","journal-title":"Chromatographia"},{"key":"10.1016\/j.jchromb.2020.122094_b0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0021-9673(94)01086-T","article-title":"Investigation of the stereoselective metabolism of the chiral H1-antihistaminic drug terfenadine by high-performance liquid chromatography","volume":"694","author":"Terhechte","year":"1995","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2020.122094_b0045","first-page":"155","article-title":"Establishment of reverse phase high-performance liquid chromatography with chiral reagent derivatization for separation of fexofenadine enantiomers","volume":"43","author":"Yao","year":"2014","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.jchromb.2020.122094_b0050","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.talanta.2008.02.047","article-title":"A simple and rapid high performance liquid chromatographic method with fluorescence detection for the estimation of fexofenadine in rat plasma-application to preclinical pharmacokinetics","volume":"76","author":"Pathak","year":"2008","journal-title":"Talanta"},{"key":"10.1016\/j.jchromb.2020.122094_b0055","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1365-2125.2011.04106.x","article-title":"Carbamazepine differentially affects the pharmacokinetics of fexofenadine enantiomers","volume":"73","author":"Akamine","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2020.122094_b0060","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00228-014-1705-y","article-title":"Effects of one-time apple juice ingestion on the pharmacokinetics of fexofenadine enantiomers","volume":"70","author":"Akamine","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2020.122094_b0065","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/jcpt.12213","article-title":"Effects of multiple-dose rifampicin 450 mg on the pharmacokinetics of fexofenadine enantiomers in Japanese volunteers","volume":"40","author":"Akamine","year":"2015","journal-title":"J. Clin. Pharm. Therap."},{"key":"10.1016\/j.jchromb.2020.122094_b0070","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.dmpk.2015.06.005","article-title":"The change of pharmacokinetics of fexofenadine enantiomers through the single and simultaneous grapefruit juice ingestion","volume":"30","author":"Akamine","year":"2015","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.jchromb.2020.122094_b0075","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2125.2009.03396.x","article-title":"Enantioselective disposition of fexofenadine with the P-glycoprotein inhibitor verapamil","volume":"67","author":"Sakugawa","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2020.122094_b0080","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2125.2008.03116.x","article-title":"The different effects of itraconazole on the pharmacokinetics of fexofenadine enantiomers","volume":"65","author":"Tateishi","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2020.122094_b0085","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/chir.20370","article-title":"Pharmacokinetics of fexofenadine enantiomers in healthy subjects","volume":"19","author":"Miura","year":"2007","journal-title":"Chirality"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023219317507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023219317507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T22:59:32Z","timestamp":1761605972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023219317507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":17,"alternative-id":["S1570023219317507"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2020.122094","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct chiral LC-MS\/MS analysis of fexofenadine enantiomers in plasma and urine with application in a maternal-fetal pharmacokinetic study","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2020.122094","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122094"}}